GlassScriptPhysician profile
Mohammad N Khan
NPI 1578527727
$739.32
in general payments reported to CMS, 2019-2025
16 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $54.61 · 2021: $15.87 · 2022: $21.02 · 2023: $226 · 2024: $295 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $647.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $222.46 | 2023-2025 | Eterna, Diamondback Peripheral, Perclose Prostyle |
| Sun Pharmaceutical Industries INC. | $89.31 | 2024-2025 | |
| Novo Nordisk INC | $66.56 | 2024 | Ozempic |
| E.R. Squibb & Sons, L.L.C. | $54.61 | 2020 | |
| Inari Medical, INC. | $52.63 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medicomp INC | $39.54 | 2023 | Telepatch Cardiac Monitor |
| Boston Scientific Corporation | $37.05 | 2023-2024 | Varithena Administration Pack |
| Livanova USA, INC. | $28.44 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Pharmacosmos Therapeutics INC. | $25.38 | 2025 | Monoferric |
| Aurinia Pharma U.S., INC. | $24.79 | 2024 | Lupkynis |
| Edwards Lifesciences Corporation | $21.02 | 2022 | |
| Blue Earth Diagnostics | $16.77 | 2025 | Posluma |
| Novartis Pharmaceuticals Corporation | $15.87 | 2021 | |
| Cardiovascular Systems INC. | $15.41 | 2023 | Diamondback Peripheral |
| Janssen Pharmaceuticals, INC | $14.77 | 2023 | Xarelto |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $14.71 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.